[ET Net News Agency, 15 December 2021] LUYE PHARMA (02186) fell 0.88% to HK$3.39.
It hits an intra-day low of HK$3.39, hitting a historical low, and an intra-day high of
HK$3.5. The total shares traded was 6.58 million, with a value of HK$22.76m. The active
buy/sell ratio is 61:39, with net buying turnover of HK$4.8m. CHINA INV INFO accounts for
greatest net responsive buying turnover of HK$908,106, with volume weighted average price
of HK$3.458. UBS SEC accounts for greatest net responsive selling turnover of HK$2.13m,
with volume weighted average price of HK$3.454. The stock has fallen a combined 9.12% over
the past 4 consecutive trading days.
The Hang Seng Index now fell 309 points, or 1.31% to 23,326; the Hang Seng China
Enterprises Index now fell 107 points, or 1.27% to 8,311; the Hang Seng TECH Index now
fell 126 points, or 2.15% to 5,758; with an overall turnover of HK$98.96b.
The SSE Composite Index now fell 13 points, or 0.38% to 3,647, with an overall turnover
of RMB481.13b.
The SZSE Component Index now fell 110 points, or 0.73% to 15,026, with an overall
turnover of RMB289.33b.
Basic Information
=================
--------------------------------
Nominal 3.390 % Chg -0.88%
High 3.500 Low 3.390
Shares Tr 6.58m Turnover 22.76m
10-D SMA 3.593 %H.V 28.520
20-D SMA 3.652 VWAP 3.456
50-D SMA 3.740 RSI14 32.303
--------------------------------
Status: Hitting a historical low, active buy/sell ratio is 61:39, with net buying turnover
of HK$4.8m, falling a combined 9.12% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
LUYE PHARMA (02186) 3.39 -0.88
TRAD CHI MED (00570) 3.83 +2.41
CSPC PHARMA (01093) 8.11 -3.45
SINO BIOPHARM (01177) 5.23 -6.27
3SBIO (01530) 6.51 -6.60
FOSUN PHARMA (02196) 34.25 -7.31
WUXI APPTEC (02359) 132.20 -18.19
SH PHARMA (02607) 14.20 +2.31
PHARMARON (03759) 121.80 -16.46
ASYMCHEM (06821) 329.00 -7.27
---------------------------------------------
(ed)